In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Rocket Pharmaceuticals Inc (NASDAQ: RCKT) was $6.97 for the day, down -2.79% from the previous closing price of $7.17. In other words, the price has decreased by -$2.79 from its previous closing price. On the day, 3.9 million shares were traded. RCKT stock price reached its highest trading level at $7.28 during the session, while it also had its lowest trading level at $6.73.
Ratios:
Our analysis of RCKT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.30 and its Current Ratio is at 9.30. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BMO Capital Markets on March 12, 2025, initiated with a Outperform rating and assigned the stock a target price of $50.
On December 30, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $32.
On December 18, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $29.Jefferies initiated its Buy rating on December 18, 2024, with a $29 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 22 ’25 when Militello John bought 718 shares for $7.16 per share.
Shah Gaurav bought 20,000 shares of RCKT for $101,600 on Apr 10 ’25. The CEO now owns 792,680 shares after completing the transaction at $5.08 per share. On Apr 09 ’25, another insider, Patel Kinnari, who serves as the insider of the company, bought 21,099 shares for $4.70 each. As a result, the insider paid 99,165 and bolstered with 26,774 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 743211072 and an Enterprise Value of 396371008.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.93, which has changed by -0.705036 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $26.98, while it has fallen to a 52-week low of $4.55. The 50-Day Moving Average of the stock is -13.98%, while the 200-Day Moving Average is calculated to be -51.83%.
Shares Statistics:
RCKT traded an average of 2.26M shares per day over the past three months and 4343930 shares per day over the past ten days. A total of 106.45M shares are outstanding, with a floating share count of 98.94M. Insiders hold about 7.22% of the company’s shares, while institutions hold 101.67% stake in the company. Shares short for RCKT as of 1743379200 were 12437730 with a Short Ratio of 5.51, compared to 1740700800 on 11035189. Therefore, it implies a Short% of Shares Outstanding of 12437730 and a Short% of Float of 21.260001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
